SO
PRME icon

STRS Ohio’s Prime Medicine PRME Stock Holding History

STRS Ohio’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$51.4K – 2056
2024
Q2 		$51.4K Sell
10,000
-24,000
-71% -$145K ﹤0.01% 1795
2024
Q1 		$238K Buy
34,000
+16,900
+99% +$128K ﹤0.01% 1507
2023
Q4 		$151K Buy
+17,100
New +$132K ﹤0.01% 1632
2023
Q2 		– Sell
-2,400
Closed -$29K – 2067
2023
Q1 		$29K Hold
2,400
– – ﹤0.01% 1838
2022
Q4 		$44K Buy
+2,400
New +$43.4K ﹤0.01% 1819

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

STRS Ohio's PRME Position: Q3 2024 in Review

STRS Ohio sold out of Prime Medicine (PRME) in Q3 2024, closing a stake of 10,000 shares — an estimated $51.4K sold.

STRS Ohio first reported a position in PRME in Q4 2022 and held it in 5 quarters. The position peaked at $238K in Q1 2024. 116 funds tracked by Wall St. Rank hold PRME as of Q3 2024.

  • STRS Ohio reported no remaining Prime Medicine position as of Q3 2024 after selling out during the quarter.
  • STRS Ohio sold 10,000 Prime Medicine shares in Q3 2024, an estimated $51.4K.
  • STRS Ohio first reported a position in Prime Medicine in Q4 2022 and held it in 5 quarters.
  • STRS Ohio's Prime Medicine position peaked at $238K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.